Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

A summary of the included study characteristics. by Zahra Tajik (20752452)

Subjects:

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Mean counts of fish caught per unit effort (± SE) per reef type. by Maryann S. Watson (16879881)

Linear regression analysis. by Young Kyu Lee (14076058)

“…</p><p> Conclusion </p><p>The HTRT group showed a greater decrease in HU both pre- and post-treatment, indicating a possible indirect marker of tumor necrosis. …”

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

List of Included studies. by Zahra Tajik (20752452)

Subjects:

The search strategy in three databases. by Zahra Tajik (20752452)

Subjects:

NIH score. by Zahra Tajik (20752452)

Subjects:

List of excluded studies. by Zahra Tajik (20752452)

Subjects:

Table_2_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX by Sara Gonia (14132166)

“…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”

Table_1_Maternal oral probiotic use is associated with decreased breastmilk inflammatory markers, infant fecal microbiome variation, and altered recognition memory responses in infants—a pilot observational study.XLSX by Sara Gonia (14132166)

“…Probiotic use has been proposed as a strategy to promote health via modulation of microbiomes. …”

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

FGF18 injections increase TIMP1 and decrease MMP13 and NOGGIN, suggesting healing of degeneration induction of anabolic effect. by Flavia Gomes Velasque Gama (21175112)

Open data. by Larissa Brazolotto Ferreira (17671168)

Subjects:

Mean KAP scores and standard deviation at different assessment times. by Chikondi Maluwa (20660522)

Processing of wakefulness and sleep EEG data to calculate the HFD in a representative subject. by Francesco Colussi (22421582)

Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

“…</p><p dir="ltr"><b>Method: </b>Twenty-six people with HVDs and 26 matched controls participated in tasks to assess the smallest volitional increases and decreases they could make in vocal <i>F</i>0 and intensity. …”